Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up
Background Dimethyl fumarate and fingolimod are oral disease-modifying therapies approved to treat relapsing multiple sclerosis. Prior observational studies and our previous 12-month investigation showed comparable clinical efficacy. Objective The purpose of this study was to assess real-world effic...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publishing
2017-08-01
|
| Seri Bilgileri: | Multiple Sclerosis Journal - Experimental, Translational and Clinical |
| Online Erişim: | https://doi.org/10.1177/2055217317715485 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|